The DOI matches its Crossref record; 404 of the 409 references it cites were found in a registry or an index.
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Abstract
G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiological functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension. Pharmacological agents targeting dopaminergic neurotransmission have been clinically used in the management of several neurological and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD(1)), and Tourette's syndrome. Numerous advances have occurred in understanding the general structural, biochemical, and functional properties of dopamine receptors that have led to the development of multiple pharmacologically active compounds that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics. Recent progress in understanding the complex biology of dopamine receptor-related signal transduction mechanisms has revealed that, in addition to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins. One of the future directions in managing dopamine-related pathologic conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacology. In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms. In addition, we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacology and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with five dopamine receptors (D1-5), three norepinephrine receptors each with three subtypes (α1a,b,d, α2a,b,c and β1,2,3) and seven serotonin receptor families (5-HT1-7) comprised of 14 total receptors all of which are G-protein coupled, except for 5-HT3”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Beaulieu & Gainetdinov, 2011
Citations
Cites
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,756
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,712
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113009 · Cited by 2,647
Sokoloff, P., Bruno Giros, A., Martres, M., Bouthenet, M.-L., & Schwartz, J. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,608
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Cited by
Sorted by citations
Items 601–700 of 1,006
SU-8 based pyrolytic carbon for the electrochemical detection of dopamine
Peltola, E., Heikkinen, J. J., Sovanto, K., Sainio, S., Aarva, A., Franssila, S., Jokinen, V. P., & Laurila, T. T. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb02469j · Cited by 41
Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease
Cardinale, A., & Fusco, F. R. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12834 · Cited by 41
Dopamine Receptor Subtypes Differentially Regulate Autophagy
Wang, D., Ji, X., Liu, J., Li, Z., & Zhang, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051540 · Cited by 41
Salazar, P., Martín, M. E., & González–Mora, J. L. (2019) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2019.02.032 · Cited by 41
Gangarossa, G., Castell, L., Castro, L. R., Tarot, P., Veyrunes, F., Vincent, P., Bertaso, F., & Valjent, E. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14804 · Cited by 41
Svensson, K. A., Hao, J., & Bruns, R. F. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.06.001 · Cited by 41
Newman, A. H., Xi, Z., & Heidbreder, C. A. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_347 · Cited by 41
Zhang, W., Lei, M., Wen, Q., Zhang, D., Qin, G., Zhou, J., & Chen, L. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01469-x · Cited by 41
López-Muciño, L. A., García‐García, F., Cueto‐Escobedo, J., Acosta-Hernández, M. E., Venebra-Muñoz, A., & Rodríguez‐Alba, J. C. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104832 · Cited by 41
Zou, M., Keck, T. M., Kumar, V., Donthamsetti, P., Michino, M., Burzynski, C., Schweppe, C. A., Bonifazi, A., Free, R. B., Sibley, D. R., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01612 · Cited by 41
Zhang, S., Yang, J., Reinach, P. S., Wang, F., Zhang, L., Fan, M., Ying, H., Pan, M., Qu, J., & Zhou, X. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21574 · Cited by 41
Ortinski, P. I., Briand, L. A., Pierce, R. C., & Schmidt, H. D. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.002 · Cited by 40
Discovery of GPCR ligands for probing signal transduction pathways
Brogi, S., Tafi, A., Désaubry, L., & Nebigil, C. G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00255 · Cited by 40
Molecular Determinants of Biased Agonism at the Dopamine D2Receptor
Weichert, D., Banerjee, A., Hiller, C., Kling, R. C., Hübner, H., & Gmeiner, P. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501889t · Cited by 40
Dobbs, L. K., Lemos, J. C., & Alvarez, V. A. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12361 · Cited by 40
Calcium, Dopamine and Neuronal Calcium Sensor 1: Their Contribution to Parkinson’s Disease
Catoni, C., Calí, T., & Brini, M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00055 · Cited by 40
Powell, A., Ireland, C., & Lewis, S. J. G. (2020) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.19110316 · Cited by 40
Mustafá, E. R., González, S. C., Damian, M., Cantel, S., Denoyelle, S., Wagner, R., Schiöth, H. B., Fehrentz, J., Banères, J., Perelló, M., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.712437 · Cited by 40
Catecholamines Mediate Psychologic Stress–Induced Cancer Progression
Bernabé, D. G. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-3077 · Cited by 40
Khushboo, Siddiqi, N. J., Pereira, M. D. L., & Sharma, B. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02780-z · Cited by 40
Sleep deprivation differentially affects dopamine receptor subtypes in mouse striatum
Lim, M. M., Xu, J., Holtzman, D. M., & Mach, R. H. (2011) · Neuroreport · doi:10.1097/wnr.0b013e32834846a0 · Cited by 40
Song, R., Zhang, H., Peng, X., Su, R., Yang, R., Li, J., Xi, Z., & Gardner, E. L. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.042 · Cited by 40
Srivastava, P., Dhuriya, Y. K., Gupta, R., Shukla, R. K., Yadav, R. S., Dwivedi, H. N., Pant, A. B., & Khanna, V. K. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0288-2 · Cited by 40
LOONEN, A. J. M., & Ivanova, S. А. (2022) · Acta Neuropsychiatrica · doi:10.1017/neu.2022.15 · Cited by 39
Wang, W., Xie, X., Zhuang, X., Huang, Y., Tan, T., Gangal, H., Huang, Z., Purvines, W., Wang, X., Stefanov, A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112089 · Cited by 39
Gould, R. W., Duke, A. N., & Nader, M. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.004 · Cited by 39
Rahman, S. F., Min, K., Park, S.-H., Park, J.-H., Yoo, J. C., & Park, D.-H. (2016) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-016-0382-3 · Cited by 39
A Complete Assessment of Dopamine Receptor- Ligand Interactions through Computational Methods
Bueschbell, B., Barreto, C. A. V., Preto, A. J., Schiedel, A. C., & Moreira, I. S. (2019) · Molecules · doi:10.3390/molecules24071196 · Cited by 39
Martini, M. L., Ray, C., Yu, X., Liu, J., Pogorelov, V. M., Wetsel, W. C., Huang, X., McCorvy, J. D., Caron, M. G., & Jin, J. J. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00410 · Cited by 39
Ko, I., Kim, C., & Kim, H. K. (2019) · Journal of Exercise Rehabilitation · doi:10.12965/jer.1938316.158 · Cited by 39
Meseck, S. L., Sennefelder, G., Krisak, M., & Wikfors, G. H. (2020) · Ecological Indicators · doi:10.1016/j.ecolind.2020.106675 · Cited by 39
Retinal Dopamine D2 Receptors Participate in the Development of Myopia in Mice
Huang, F., Shu, Z., Huang, Q., Chen, K., Yan, W., Wu, W., Yang, J., Wang, Q., Wang, F., Zhang, C., et al. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.1.24 · Cited by 39
Emerging Roles of FTO in Neuropsychiatric Disorders
Chang, R., Huang, Z., Zhao, S., Zou, J., Li, Y., & Tan, S. (2022) · BioMed Research International · doi:10.1155/2022/2677312 · Cited by 39
Askland, K. D., Read, C., O’Connell, C. P., & Moore, J. H. (2011) · Human Genetics · doi:10.1007/s00439-011-1082-x · Cited by 39
Wang, S., Mou, Z.-Z., Ma, Y., Li, J., Li, J., Ji, X., Wu, K., Li, L., Lu, W., & Zhou, T. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.03.013 · Cited by 39
Sidharthan, N. P., Minchin, R. F., & Butcher, N. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.493239 · Cited by 39
Brust, T. F., Hayes, M. P., Roman, D. L., Burris, K. D., & Watts, V. J. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.220293 · Cited by 39
Repurposing dopaminergic drugs for MS — the evidence mounts
Marino, F., & Cosentino, M. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.33 · Cited by 38
Gao, H., Zhang, Y., Luo, D., Xu, J., Tan, S., Li, Y., Qi, W., Zhai, Q., & Wang, Q. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03514-5 · Cited by 38
Current Review of the Function and Regulation of Tuberoinfundibular Dopamine Neurons
Qi-Lytle, X., Sayers, S., & Wagner, E. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010110 · Cited by 38
Li, X., Xiao, D., Ou, X., McCullum, C., & Liu, Y. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.10.020 · Cited by 38
Intranasal Delivery of a Peptide with Antidepressant-Like Effect
Brown, V., & Liu, F. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.61 · Cited by 38
Stimulation of dopamine D 1 receptor improves learning capacity in cooperating cleaner fish
Messias, J. P. M., Santos, T. P., Pinto, M., & Soares, M. C. (2016) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2015.2272 · Cited by 40
Cross interaction of dopaminergic and adrenergic systems in neural modulation.
Lei, S. (2014) · Europe PMC (PubMed Central) · Cited by 38
Disentangling the diverse roles of dopamine D2 receptors in striatal function and behavior
Gallo, E. F. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.01.022 · Cited by 38
Kurzina, N. P., Aristova, I., Volnova, A. B., & Gainetdinov, R. R. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112642 · Cited by 38
Self-citationCheng, Z.-Y., Xia, Q.-P., Hu, Y., Wang, C., & He, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106963 · Cited by 38
Liu, Q., Zhang, R., Zhang, X., Liu, J., Wu, H., Li, Y., Cui, M., Li, T., Song, H., Gao, J., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02816-0 · Cited by 38
Dopamine Modulation of Motor and Sensory Cortical Plasticity among Vertebrates
Macêdo-Lima, M., & Remage‐Healey, L. (2021) · Integrative and Comparative Biology · doi:10.1093/icb/icab019 · Cited by 38
Role of Amine Neurotransmitters and Their Receptors in Skin Pigmentation: Therapeutic Implication
Enkhtaivan, E., & Lee, C. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158071 · Cited by 38
Wang, Y., Li, L., Jiang, M., Yang, X., Yu, X., & Xu, L. (2021) · Applied Surface Science · doi:10.1016/j.apsusc.2021.151457 · Cited by 38
Malén, T., Karjalainen, T., Isojärvi, J., Vehtari, A., Bürkner, P., Putkinen, V., Kaasinen, V., Hietala, J. A., Nuutila, P., Rinne, J. O., et al. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119149 · Cited by 40
Dopamine and norepinephrine are embracing their immune side and so should we
Gaskill, P. J., & Khoshbouei, H. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102626 · Cited by 38
Yu, A., Wang, X., Zuo, Z., Cai, J., & Wang, C. (2012) · Aquatic Toxicology · doi:10.1016/j.aquatox.2012.12.008 · Cited by 38
Subthalamic deep brain stimulation differently alters striatal dopaminergic receptor levels in rats
Carcenac, C., Favier, M., Vachez, Y. M., Lacombe, E., Carnicella, S., Savasta, M., & Boulet, S. (2015) · Movement Disorders · doi:10.1002/mds.26146 · Cited by 38
Lauretti, E., Meco, A. D., Merali, S., & Praticò, D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.1 · Cited by 38
Modulation of Dopaminergic Pathways to Treat Erectile Dysfunction
Simonsen, U., Comerma-Steffensen, S., & Andersson, K. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12653 · Cited by 38
Gupta, R., Shukla, R. K., Pandey, A., Sharma, T., Dhuriya, Y. K., Srivastava, P., Singh, M. P., Siddiqi, M. I., Pant, A. B., & Khanna, V. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-20342-z · Cited by 38
Pharmacogenomic Biomarkers and Their Applications in Psychiatry
Kam, H., & Jeong, H. (2020) · Genes · doi:10.3390/genes11121445 · Cited by 37
A role for dopamine in C. elegans avoidance behavior induced by mitochondrial stress
Chou, S., Chen, Y., Liao, C., & Pan, C. (2022) · Neuroscience Research · doi:10.1016/j.neures.2022.01.005 · Cited by 37
Kaczor, A. A., Jörg, M., & Capuano, B. (2016) · Journal of Molecular Modeling · doi:10.1007/s00894-016-3065-2 · Cited by 37
Blockade of neuronal dopamine D2 receptor attenuates morphine tolerance in mice spinal cord
Dai, W., Xiong, F., Yan, B., Cao, Z., Liu, W., Liu, J.-H., & Yu, B. (2016) · Scientific Reports · doi:10.1038/srep38746 · Cited by 37
Behavioral Modulation by Spontaneous Activity of Dopamine Neurons
Ichinose, T., Tanimoto, H., & Yamagata, N. (2017) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2017.00088 · Cited by 37
Chen, Y.-H., Kuo, T., Kao, J., Huang, E. Y., Hsieh, T.-H., Chou, Y., & Hoffer, B. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22462-y · Cited by 37
Reduced level of docosahexaenoic acid shifts GPCR neuroreceptors to less ordered membrane regions
Javanainen, M., Enkavi, G., Guixà-González, R., Kulig, W., Martinez‐Seara, H., Levental, I., & Vattulainen, I. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007033 · Cited by 37
Barroso‐Chinea, P., Luis-Ravelo, D., Fumagallo-Reading, F., Castro‐Hernández, J., Salas-Hernández, J., Rodríguez-Núñez, J., Febles-Casquero, A., Cruz‐Muros, I., Afonso‐Oramas, D., Abreu-González, P., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1668606 · Cited by 37
Directing Technology Addiction Research in Information Systems
Serenko, A., & Turel, O. (2020) · ACM SIGMIS Database the DATABASE for Advances in Information Systems · doi:10.1145/3410977.3410982 · Cited by 37
Li, J., Huang, X. H., Shi, W., Jiang, M., Tian, L., Su, M., Wu, J., Liu, Q., Yu, C., & Gu, H. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.129311 · Cited by 37
Lin, M., Mackie, P. M., Shaerzadeh, F., Gamble‐George, J., Miller, D. R., Martyniuk, C. J., & Khoshbouei, H. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01203-9 · Cited by 37
The Prevention and Treatment of Delirium in Elderly Patients Following Hip Fracture Surgery
Martocchia, A., Curto, M., Comite, F., Scaccianoce, S., Girardi, P., Ferracuti, S., Nicoletti, F., Falaschi, P., & Bentham Science Publisher Orthogeriatric Group (2015) · Recent Patents on CNS Drug Discovery · doi:10.2174/1574889810666150216152624 · Cited by 37
Wu, S., Xu, G., STANLEY, D. W., Huang, J., & Yè, G. (2015) · Scientific Reports · doi:10.1038/srep12247 · Cited by 37
Yohn, S. E., Galbraith, J., Calipari, E. S., & Conn, P. J. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00601 · Cited by 36
Exploring neurotransmitters and their receptors for breast cancer prevention and treatment
Li, R. Q., Zhao, X. H., Zhu, Q., Liu, T., Hondermarck, H., Thorne, R. F., Zhang, X. D., & Gao, J. N. (2023) · Theranostics · doi:10.7150/thno.81403 · Cited by 36
Dopamine D2 receptors in pyramidal neurons in the medial prefrontal cortex regulate social behavior
Chen, H. H., Xiong, X.-X., Jin, S.-Y., He, X., He, X., Yang, J.-M., Gao, T., & Chen, Y. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.107042 · Cited by 36
Jiang, Q., Tian, L., Zhao, L., Sun, Y., Mao, Z., Xing, Y., Wang, C., & Bo, Q. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1337274 · Cited by 36
Using click chemistry toward novel 1,2,3-triazole-linked dopamine D3 receptor ligands
Keck, T. M., Banala, A. K., Slack, R. D., Burzynski, C., Bonifazi, A., Bakare, O. M., Moore, M., Deschamps, J. R., Rais, R., Slusher, B. S., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.017 · Cited by 36
Brust, T. F., Hayes, M. P., Roman, D. L., & Watts, V. J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.10.014 · Cited by 36
Dopamine directly increases mitochondrial mass and thermogenesis in brown adipocytes
Kohlie, R., Perwitz, N., Resch, J., Schmid, S. M., Lehnert, H., Klein, J. C., & Iwen, K. A. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0159 · Cited by 36
Fountaine, M. F. L. (2017) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2017.11.016 · Cited by 36
Huang, F., Zhang, L., Wang, Q., Yang, Y., Li, Q., Wu, Y. J., Chen, J., Qu, J., & Zhou, X. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22578 · Cited by 36
Zhang, X., Nagai, T., Ahammad, R. U., Kuroda, K., Nakamuta, S., Nakano, T., Yukinawa, N., Funahashi, Y., Yamahashi, Y., Amano, M., et al. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.10.008 · Cited by 36
REST-DRD2 mechanism impacts glioblastoma stem cell–mediated tumorigenesis
Marisetty, A., Lu, L., Veo, B. L., Liu, B., Coarfa, C., Kamal, M. M., Kassem, D. H., Irshad, K., Lu, Y., Gumin, J., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz030 · Cited by 36
Khan, E. A., Bertotto, L. B., Dale, K., Lille‐Langøy, R., Yadetie, F., Karlsen, O. A., Goksøyr, A., Schlenk, D., & Arukwe, A. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b00637 · Cited by 36
Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord
Brewer, K. L., Baran, C. A., Whitfield, B. R., Jensen, A. M., & Clemens, S. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00062 · Cited by 36
The effects of cannabis use on salience attribution: a systematic review
Wijayendran, S. B., O’Neill, A., & Bhattacharyya, S. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.58 · Cited by 36
Tishler, T. A., Bartzokis, G., Lu, P. H., Raven, E. P., Khanoyan, M., Kirkpatrick, C. J., Pyle, M., Villablanca, J. P., Altshuler, L. L., Mintz, J., et al. (2017) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.03.007 · Cited by 36
Horst, N. K., Jupp, B., Roberts, A., & Robbins, T. W. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0272-9 · Cited by 36
Laurila, T. T., Rautiainen, A., Sintonen, S., Jiang, H., Kaivosoja, E., & Koskinen, J. (2013) · Materials Science and Engineering C · doi:10.1016/j.msec.2013.09.035 · Cited by 35
Zheng, R., Yang, L., Sikorski, M. A., Enns, L. C., Czyzyk, T. A., Ladiges, W., & McKnight, G. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219542110 · Cited by 35
McHenry, J. A., Bell, G. A., Parrish, B. P., & Hull, E. M. (2012) · Behavioral Neuroscience · doi:10.1037/a0028707 · Cited by 35
Vengeliene, V., Bespalov, A., Roßmanith, M., Horschitz, S., Berger, S. M., Relo, A. L., Noori, H. R., Schneider, P., Enkel, T., Bartsch, D., et al. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027623 · Cited by 35
Papaleonidopoulos, V., Kouvaros, S., & Papatheodoropoulos, C. (2018) · Synapse · doi:10.1002/syn.22033 · Cited by 35
Dopamine Triggers CTCF-Dependent Morphological and Genomic Remodeling of Astrocytes
Galloway, A. L., Adeluyi, A., O’Donovan, B., Fisher, M. L., Rao, C. N., Critchfield, P., Sajish, M., Turner, J. R., & Ortinski, P. I. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3349-17.2018 · Cited by 35
Polydopamine as the Antigen Delivery Nanocarrier for Enhanced Immune Response in Tumor Immunotherapy
Wang, N., Yang, Y., Wang, X., Tian, X., Qin, W., Wang, X., Liang, J., Zhang, H., & Leng, X. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00359 · Cited by 35
Nickoloff-Bybel, E. A., Mackie, P. M., Runner, K., Matt, S. M., Khoshbouei, H., & Gaskill, P. J. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.08.191 · Cited by 35
Moreno‐Delgado, D., Puigdellívol, M., Moreno, E., Rodríguez-Ruiz, M., Botta, J. A., Gasperini, P., Chiarlone, A., Howell, L. A., Scarselli, M., Casadó, V., et al. (2020) · eLife · doi:10.7554/elife.51093 · Cited by 35
Endocannabinoid and dopaminergic system: the pas de deux underlying human motivation and behaviors
Laksmidewi, A. A. A. P., & Soejitno, A. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02326-y · Cited by 35
Molecular Engineered Carbon-Based Sensor for Ultrafast and Specific Detection of Neurotransmitters
Suriyaprakash, J., Bala, K., Shan, L., Wu, L., & Gupta, N. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c18137 · Cited by 35
Sheta, R., Teixeira, M., Idi, W., Pierre, M., Jacquet, A. D. R., Émond, V., Zorca, C. E., Vanderperre, B., Durcan, T. M., Fon, E. A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-22158-4 · Cited by 35
Ferraiolo, M., & Hermans, E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108392 · Cited by 36
Metadata
- Authors
- Beaulieu, J.-M., & Gainetdinov, R. R.
- Affiliations
- Université Laval (CA)
- Italian Institute of Technology (IT)
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 63
- Issue
- 1
- Pages
- 182-217
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2097744565
- Cited by
- 2,763
- References
- 409
- Citations by year
- 2026: 157 · 2025: 183 · 2024: 172 · 2023: 193 · 2022: 201 · 2021: 197 · 2020: 198 · 2019: 220 · 2018: 200 · 2017: 187 · 2016: 205 · 2015: 175 · 2014: 194 · 2013: 136 · 2012: 101
- FWCI
- 13.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacological Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (NSA93798)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- dopamine receptors, dopamine D1/D5 receptors, G protein-coupled receptors, signal transduction, cAMP signaling, G protein-independent signaling, beta-arrestin, receptor desensitization, antiparkinsonian drugs, antipsychotic drugs
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Ligands, Receptors, Dopamine, Signal Transduction, Dopamine Agonists, Dopamine Antagonists, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review